727 results on '"Fisher, William E."'
Search Results
2. The road to tailored adjuvant chemotherapy for all four non-pancreatic periampullary cancers: An international multimethod cohort study
3. Use of pancreatic endotherapy in patients with chronic pancreatitis: results from a multicenter cohort study in the United States
4. Tackling challenges in rare diseases: The ISGACA approach on non-pancreatic cancers in the periampullary region
5. Circulating immune signatures in chronic pancreatitis with and without preceding acute pancreatitis: A pilot study
6. Serum Biomarkers of Nociceptive and Neuropathic Pain in Chronic Pancreatitis
7. Association of Chronic Pancreatitis Pain Features With Physical, Mental, and Social Health
8. Distinct Serum Immune Profiles Define the Spectrum of Acute and Chronic Pancreatitis From the Multicenter Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED) Study
9. T1 signal intensity ratio of the pancreas as an imaging biomarker for the staging of chronic pancreatitis
10. Rapid diagnosis and tumor margin assessment during pancreatic cancer surgery with the MasSpec Pen technology
11. Diagnostic and Prognostic Biomarkers of Chronic Pancreatitis: A Conceptual Framework Based on the PRoBE Design
12. Standard Operating Procedures for Biospecimen Collection, Processing, and Storage
13. A Prospective Study to Establish a New-Onset Diabetes Cohort
14. PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies
15. A risk-adjusted analysis of drain use in pancreaticoduodenectomy: Some is good, but more may not be better
16. Characterizing mechanism-based pain phenotypes in patients with chronic pancreatitis: a cross-sectional analysis of the PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies
17. Hemoglobin A1c Is a Predictor of New Insulin Dependence After Partial Pancreatectomy: A Multi-Institutional Analysis
18. The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation
19. Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer
20. Real-Time Reporting of Complications in Hospitalized Surgical Patients by Surgical Team Members Using a Smartphone Application
21. The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysis
22. The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy
23. Characterizing mechanism-based pain phenotypes in patients with chronic pancreatitis: a cross-sectional analysis of the PROCEED study.
24. Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula development
25. Development and external validation of a prediction model for survival in patients with resected ampullary adenocarcinoma
26. Lactoferrin amyloid presenting as a mural nodule in a pancreatic cystic lesion prompting pancreatoduodenectomy: a case report
27. Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy
28. Circulating immune signatures across clinical stages of chronic pancreatitis: a pilot study.
29. Nanoparticle-Mediated Therapy with miR-198 Sensitizes Pancreatic Cancer to Gemcitabine Treatment through Downregulation of VCP-Mediated Autophagy
30. The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy
31. Diagnostic and Prognostic Biomarkers of Chronic Pancreatitis: A Conceptual Framework Based on the PRoBE Design
32. Intraperitoneal Drainage and Pancreatic Resection
33. Sequential drain amylase to guide drain removal following pancreatectomy
34. The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy
35. Notch1 activation up-regulates pancreatic and duodenal homeobox-1.
36. Supplementary Fig. S1 from Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment
37. Supplementary Tables 1-5 from Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment
38. Data from Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment
39. Distinct Serum Immune Profiles Define the Spectrum of Acute and Chronic Pancreatitis From the Multicenter Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED) Study
40. Value of lymph node positivity in treatment planning for early stage pancreatic cancer
41. Interobserver Variability and Challenges in Intraoperative Frozen Section Evaluation of Pancreatic Margins in Pancreatectomy Specimens.
42. Supplementary Material from Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer
43. Supplementary Data from Specific Targeting of Somatostatin Receptor Subtype-2 for Fluorescence-Guided Surgery
44. Supplementary Figure 7 from A Tumorigenic Factor Interactome Connected through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer
45. Supplementary Figure 2 from A Tumorigenic Factor Interactome Connected through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer
46. Supplementary Figure 4 from A Tumorigenic Factor Interactome Connected through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer
47. Supplementary Results and Methods from A Tumorigenic Factor Interactome Connected through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer
48. Supplementary Figure 6 from A Tumorigenic Factor Interactome Connected through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer
49. Supplementary Figure 1 from A Tumorigenic Factor Interactome Connected through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer
50. Supplementary Figure 5 from A Tumorigenic Factor Interactome Connected through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.